Nakamura Eiki, Makita Yoshio, Okamoto Toshio, Nagaya Ken, Hayashi Tokitsugi, Sugimoto Masaya, Manabe Hiromi, Taketazu Genya, Kajino Hiroki, Fujieda Kenji
Department of Pediatrics, Asahikawa Medical College, 2-1-1-1 Midorigaoka Higashi, Asahikawa, Hokkaido 078-8510, Japan.
Eur J Med Genet. 2011 May-Jun;54(3):354-6. doi: 10.1016/j.ejmg.2010.12.004. Epub 2010 Dec 21.
All patients with terminal deletion of chromosome 15q have been reported to show intrauterine growth retardation, postnatal growth retardation, abnormal facial appearance and developmental delay. Haploinsufficiency of IGF1R was considered to be responsible for these symptoms. However, it is difficult to explain other symptoms seen in some of the patients, such as congenital heart defects by the absence of IGF1R alone. Here, we reported a patient with congenital heart defects and a 5.78 Mb terminal deletion of chromosome 15q detected by array-CGH. Among the patients reported to share congenital heart defects and terminal deletion of chromosome 15q, our patient had the smallest deletion. Evaluating the deletion map, NR2F2 was considered a candidate gene contributing to congenital heart defects in patients with terminal deletion of chromosome 15q.
据报道,所有15号染色体长臂末端缺失的患者均表现出宫内生长迟缓、出生后生长迟缓、面部外观异常和发育迟缓。IGF1R单倍剂量不足被认为是这些症状的原因。然而,仅靠IGF1R的缺失很难解释部分患者出现的其他症状,如先天性心脏缺陷。在此,我们报告了1例通过阵列比较基因组杂交检测到15号染色体长臂末端有5.78 Mb缺失且患有先天性心脏缺陷的患者。在已报道的患有先天性心脏缺陷且15号染色体长臂末端缺失的患者中,我们的患者缺失区域最小。通过评估缺失图谱,NR2F2被认为是导致15号染色体长臂末端缺失患者先天性心脏缺陷的候选基因。